|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
73,830,000 |
Market
Cap: |
3.85(B) |
Last
Volume: |
282,124 |
Avg
Vol: |
696,159 |
52
Week Range: |
$36.45 - $67.51 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Electronics |
Level
III Sector: |
Semiconductor Equipment & Materials |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
NASDAQ COMPUTER |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 443 |
Guru Rank Value : 3.1 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Azenta provides life science sample exploration and management solutions. Co.'s segments are: Life Sciences Products, which provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and instruments; and Life Sciences Services, which provides sample management programs, cold chain solutions, informatics, as well as sample-based laboratory services, including sample storage, genomic sequencing, gene synthesis, laboratory processing services, laboratory analysis, biospecimen procurement services and other support services to scientific research and support drug development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
12,975 |
Total Buy Value |
$0 |
$0 |
$0 |
$752,191 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
39,197 |
39,197 |
Total Sell Value |
$0 |
$0 |
$2,183,306 |
$2,183,306 |
Total People Sold |
0 |
0 |
2 |
2 |
Total Sell Transactions |
0 |
0 |
5 |
5 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Zhou Ginger |
SVP and General Manager, Genom |
|
2023-11-16 |
4 |
A |
$54.57 |
$175,006 |
D/D |
3,207 |
12,494 |
|
- |
|
Zhou Ginger |
SVP and General Manager, Genom |
|
2023-11-16 |
4 |
D |
$53.81 |
$24,645 |
D/D |
(458) |
9,287 |
|
- |
|
Vacha Robin |
SVP, GM Life Science Products |
|
2023-11-16 |
4 |
A |
$54.57 |
$250,040 |
D/D |
4,582 |
30,963 |
|
- |
|
Vacha Robin |
SVP, GM Life Science Products |
|
2023-11-16 |
4 |
D |
$53.81 |
$158,524 |
D/D |
(2,946) |
26,381 |
|
- |
|
Hughes Violetta |
VP, Chief Accounting Officer |
|
2023-11-16 |
4 |
A |
$54.57 |
$74,979 |
D/D |
1,374 |
4,057 |
|
- |
|
Joseph Jason |
SVP, General Counsel, Secy. |
|
2023-11-16 |
4 |
A |
$54.57 |
$300,026 |
D/D |
5,498 |
107,006 |
|
- |
|
Joseph Jason |
SVP, General Counsel, Secy. |
|
2023-11-16 |
4 |
D |
$53.81 |
$98,526 |
D/D |
(1,831) |
101,508 |
|
- |
|
Robertson Lindon G |
EVP & Chief Financial Officer |
|
2023-11-15 |
4 |
A |
$54.13 |
$340,857 |
D/D |
6,297 |
123,860 |
|
- |
|
Gray David C |
Chief Strategy & New Business |
|
2023-11-15 |
4 |
A |
$54.13 |
$155,624 |
D/D |
2,875 |
79,917 |
|
- |
|
Schwartz Stephen S |
CEO |
|
2023-11-15 |
4 |
A |
$54.13 |
$889,139 |
D/D |
16,426 |
436,953 |
|
- |
|
Zhou Ginger |
SVP and General Manager, Genom |
|
2023-11-15 |
4 |
A |
$54.13 |
$47,472 |
D/D |
877 |
9,745 |
|
- |
|
Vacha Robin |
SVP, GM Life Science Products |
|
2023-11-15 |
4 |
A |
$54.13 |
$222,312 |
D/D |
4,107 |
29,327 |
|
- |
|
Joseph Jason |
SVP, General Counsel, Secy. |
|
2023-11-15 |
4 |
A |
$54.13 |
$192,649 |
D/D |
3,559 |
103,339 |
|
- |
|
Wang David Dong |
SVP & GM, SMSOfficer |
|
2023-11-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,409 |
|
25% |
|
Hughes Violetta |
VP, Chief Accounting OfficerOf |
|
2023-08-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,683 |
|
15% |
|
Gray David C |
Chief Strategy & New Business |
|
2023-08-11 |
4/A |
S |
$56.03 |
$609,438 |
D/D |
(10,877) |
70,610 |
|
- |
|
Gray David C |
Chief Strategy & New Business |
|
2023-08-11 |
4 |
S |
$56.03 |
$609,438 |
D/D |
(10,877) |
77,042 |
|
-14% |
|
Gray David C |
Chief Strategy & New Business |
|
2023-08-10 |
4/A |
S |
$57.24 |
$614,300 |
D/D |
(10,732) |
81,487 |
|
- |
|
Gray David C |
Chief Strategy & New Business |
|
2023-08-10 |
4 |
S |
$57.24 |
$246,762 |
D/D |
(4,311) |
87,919 |
|
-11% |
|
Vacha Robin |
SVP, GM Life Science Products |
|
2023-08-10 |
4 |
A |
$55.00 |
$407,000 |
D/D |
7,400 |
25,220 |
|
- |
|
Zane Ellen M |
Director |
|
2023-08-08 |
4 |
A |
$55.78 |
$1,046,767 |
D/D |
18,766 |
41,134 |
|
- |
|
Zhou Ginger |
SVP and General Manager, Genom |
|
2023-07-31 |
4 |
A |
$39.98 |
$2,159 |
D/D |
54 |
8,868 |
|
- |
|
Vacha Robin |
SVP, GM Life Science Products |
|
2023-07-31 |
4 |
A |
$39.98 |
$4,838 |
D/D |
121 |
32,620 |
|
- |
|
Robertson Lindon G |
EVP & Chief Financial Officer |
|
2023-07-31 |
4 |
A |
$39.98 |
$4,198 |
D/D |
105 |
117,563 |
|
- |
|
Martin Joseph R |
Director |
|
2023-06-06 |
4 |
S |
$43.07 |
$103,368 |
D/D |
(2,400) |
85,175 |
|
-12% |
|
1054 Records found
|
|
Page 2 of 43 |
|
|